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DCT1 (NRAMP2, DMT1, slc11a2) is a member of the NRAMP family and functions as general metal ion transporter in mammals; defective
DCT1 causes anemia. The driving force for metal ion transport is protonmotive force, where protons are transported in the same direction as metal
ions. The stoichiometry between metal ion and proton varies under different conditions due to mechanistic proton slip. To better understand this
phenomenon, we performed site-directed mutagenesis of DCT1 and analyzed the mutants by measurement of metal ion uptake activity and
electrophysiology in Xenopus laevis oocytes. A single reciprocal mutation, I144F, between DCT1 and the homologous yeast transporter Smf1p
located in putative transmembrane domain 2 abolished the metal ion transport activity of DCT1, significantly increased the slip currents, and
generated sodium slip currents. A double mutation adding F227I in transmembrane domain 4 to I144F in transmembrane domain 2 restored the
uptake activity of DCT1 and reduced the slip currents. These results demonstrate the importance of these regions in coupling of metal ions and
protons as well as the possible proximity of I144 and F227 in the folded structure of DCT1.
© 2007 Elsevier B.V. All rights reserved.Keywords: NRAMP; Metal ion; Proton; Coupling; Slip; Anemia1. Introduction
Metal ions are vital life elements that participate in many
metabolic processes in every living cell. However, at elevated
levels these essential nutrients are toxic. Therefore, cells must
maintain metal ion homeostasis. This is accomplished by highly
regulated processes of uptake, storage, and secretion. In the last
few years, it has become apparent that in organisms ranging from
bacteria to man, the natural resistance-associated macrophage
protein (NRAMP) family of metal ion transporters plays a major
role in metal ion homeostasis [1–5], functioning as general metal
ion transporters and transporting Mn2+, Zn2+, Cu2+, Fe2+, Cd2+,
Ni2+, and Co2+ [6–10].
Most information regarding the function of these transporters
is derived from studies of mammalian NRAMP2 (DCT1, DMT1,
Slc11a2) and the yeast transporter SMF1 expressed in Xenopus
oocytes [6–12]. Such studies demonstrated that DCT1 and Smf1p
transport divalent metal ions and protons and that this process is⁎ Tel.: +972 52 5349988; fax: +972 3 640 6018.
E-mail address: nevoyani@post.tau.ac.il.
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.10.007driven by a proton gradient [9,11]. However, the transport ofmetal
ions and protons is loosely coupled; the process exhibits variable
stoichiometry. At pH 7 and membrane potentials of −90 mV to
−30 mV, DCT1 transports one Fe2+ with one H+. At high proton
concentrations (pH 5.5), 10 H+ are transported with each Fe2+ [9].
Moreover, at this low pH, with a reduction in membrane potential
from +10 mV to −80 mV the number of H+ transported for each
Fe2+ increases from 3 to approximately 18 [11]. In DCT1, this
phenomenon is termedmetal ion-dependent proton slip [1,11,13].
In contrast, Smf1p exhibits metal ion-independent sodium slip
through the proton-translocation pathway [11,14].
Recently, in an attempt to locate the transporter sites that
mediate proton slip in DCT1, we created the mutation F227I
(Fig. 1) in the putative transmembrane (TM) domain 4 (TM4)
[10]. This mutation resulted in an increase of up to 14-fold in the
ratio of transported metal ions to transported protons without any
significant changes in metal ion transport activity and levels of
transporter expression [10]. This finding suggests that proton slip
is not a mechanistic necessity and supports the idea that proton
slip confers a physiological advantage and was positively selected
during the evolution of DCT1. However, the mechanism
Fig. 1. Schematic representation of DCT1 (A). The predicted 12 transmembrane domains and individual intracellular (In) and extracellular (Out) segments are
identified, along with their position within the primary sequence. The N- and C-termini are intracellular, and the loop between transmembrane domains 7 and 8 is
extracellular. The G216R mutation in TM4 causes microcytic anemia in mk/mk mice and Belgrade rats [19–22]. (B) Alignment between DCT1 and Smf1p, from
putative TM2 to TM4. The amino acid sequence of yeast Smf1p was obtained from ref. 6; the rat DCT1 (Nramp2) is from GenBank accession no. AF008439.
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identity of the proton translocation pathway remains unknown.
DCT1 is thought to play a crucial role in iron absorption from
the duodenum and in transport of iron released in the endosomes
of many cell types at low pH [15–17]. There are compelling
examples of the importance of DCT1. For example, Slc11a2−/−
(DCT1−/−) mice die within the first few days of life of severe
systemic iron deficiency and consequent anemia [18]. Also, a
single mutation in DCT1 (G216R) (Fig. 1) causes microcytic
anemia in mk mice and Belgrade rats [19–22]. In humans, there
are three known cases of severemicrocytic anemia in patients with
mutations in DCT1. The first two cases have been described in
detail, together with the functional properties of themutated DCT1
proteins expressed in yeast and cell lines [23–27]. Beaumont et al.
reported the third case, a 10-year-old female patient [28]. This
patient is a compound heterozygote for two novel mutations of
DCT1. The first mutation is a 3-bp deletion (del GTG) in exon
5, leading to a V145 (V114) in-frame deletion in transmembrane
domain 2 (TM2; Fig. 1), and the second mutation is a G to T
substitution in exon 8 leading to replacement of G243V (G212V)
in transmembrane domain 5 (TM5; Fig. 1) [28]. The effects of
these two mutations (V145 deletion and G243V) on DCT1
function are unknown.
In this work, we investigated proton slip in DCT1 and report
mutations that affect the uptake activity, metal ion-inducedcurrents, ion binding, and specificity of DCT1. These mutations
inform the structure and function of DCT1 and the deleterious
effect of the in-frame deletion of V145 (V114) in the DCT1
gene of an anemic patient.
2. Materials and methods
2.1. Site-Directed Mutagenesis of DCT1
Oligonucleotide-directed, site-specific mutagenesis was performed by
overlapping nucleotides with the mutation using polymerase chain reaction
(PCR) [29]. DCT1 cDNAwas cloned into the pSPORT1 plasmid and used as a
template for PCR mutagenesis. NdeI and SpeI restriction sites were introduced
at positions 145 and 1719 of the DCT1 reading frame [14]. This resulted in the
substitutions G50M, S573T, and V574S, which did not change the properties of
DCT1. The mutation was confirmed by sequence analysis. The cRNAs of DCT1
and the mutants were synthesized by in vitro transcription from their cDNAs.
Oocytes were injected with 50 μl water containing 50 ng cRNA.
2.2. Oocyte preparation and uptake measurements
Xenopus laevis oocytes were handled as previously described [14]. Uptake
experiments were performed 3 days after injections. The uptake solution for
radiotracer experiments contained 100 mM NaCl, 10 mM HEPES, 2 mM MES,
2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 2 mM L-ascorbic acid; the pH was
adjusted to 7.5 with Tris base (the levels of Tris that were used were low enough to
have minimal effects via metal ion binding). Usually, 20 oocytes were incubated in
0.5 ml of a solution containing 55FeCl2,
54MnCl2,
65ZnCl2, or
60CoCl2. The
Fig. 2. Uptake of metal ions by X. laevis oocytes expressing DCT1 and the
mutants I144F, F227I, and I144F/F227I. The uptake experiment was performed
at pH 5.5 in solution containing 100 mMNaCl, 2 mMKCl, 1 mMMgCl2, 1 mM
CaCl2, 10 mM HEPES, 2 mM MES, 2 mM ascorbic acid, and the indicated
metal ion in its chloride form at 7 μM. Each bar represents the mean (after
subtraction of the control values)±SEM (n=20). SA, specific activity.
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assessed for 30 min. The reported values are background-corrected and expressed
as specific activity (pmol/oocyte/h).
2.3. Electrophysiological experiments
Two-microelectrode voltage clamp recordings were performed and the data
were analyzed as described previously [14,30–32]. To analyze pre-steady state
currents, the current traces were fitted to I(t)= I1 exp(−t/τ1)+ I2 exp(−t/τ 2)+ Iss,
where I1 is a capacitative current with time constant τ1 associated with the oocyte
plasma membrane (τ1 is also observed in uninjected control oocytes), I2 is a
transient current associated with DCT1 expression with time constant ô2, and Iss
is the steady state current. The parameters τ1, τ2, I1, I2, and Iss were allowed to
vary. The transient charge movementsQwere obtained from the time integrals of
Itransient (t)= I2 exp(−t/τ2) during the off responses for all depolarizing potentialsFig. 3. Pre-steady state charge movements of DCT1 and the mutants I144F, F227I
oocytes, and currents were recorded in a solution containing 100 mM NaCl, 2 mM K
potential was held at −25 mV and transiently (500 ms) stepped to imposed potentia
plotted against time. The pre-steady state transient currents were obtained from the tot
currents were integrated to obtain the charge, and the charge-voltage relations were fi
exhibit pre-steady state currents. The Boltzmann parameters extrapolated from the fit
and 51 mV; z, 2, 1.9, 1.8. The time constant ô for the decay of the pre-steady state cur
mutant) for the on response and 40 ms (DCT1) and 13 ms (double mutant) for the oand fitted with the Boltzmann equation, Q=Qmax/{1+exp[(V−V0.5)zF/RT]},
where Qmax represents the total charge movement, z represents the effective
valence, and V0.5 represents the midpoint of the charge distribution [30 31]. R, T,
and F are the usual thermodynamic constants.3. Results
The two homolog proteins, mammalian DCT1 and yeast
Smf1p function as general divalent metal ion transporters. Both
use proton gradients as their motive force and exhibit similar
affinities for various metal ion substrates [9,14]. Despite their
relatively high homology (28% identity), there are a few known
differences between DCT1 and Smf1p. The most prominent
difference is in transporter slip; H+ slips through DCT1 and Na+
slips through Smf1p [13]. These differences must be due to
unconserved amino acids in both proteins. Thus, to locate the
transporter sites generating ion slip, we substituted amino acids
in DCT1 for the corresponding amino acids in Smf1p [12].
Substitution of phenylalanine in position 227 in TM4 of DCT1
(Fig. 1) for the reciprocal isoleucine of Smf1p nearly abolished
proton slip without significantly affecting metal ion transport
activity (except for a small decrease in Zn2+ and Co2+ uptake
activity) or levels of transporter expression [10].
Noncovalent interactions involving aromatic rings are
essential to protein–ligand recognition (including transitional
metal ions and protons) and to establishment of protein structure
[33–40]. Based on the assumption that phenylalanine residues
may be important to the mechanism of these two transporters,
we searched for a phenylalanine residue that is present in Smf1p
but not in DCT1. We mutated isoleucine-144 of DCT1 (Fig. 1),
located in TM2, to the corresponding phenylalanine residue of
Smf1p. We then analyzed the properties of the mutant by
expression in Xenopus oocytes, measurements of uptake
activity and recording electrophysiological parameters., and I144F/F227I. DCT1 and mutant transporters were expressed in X. laevis
Cl, 1 mMMgCl2, 1 mM CaCl2, 10 mM HEPES and 2 mMMES. The membrane
ls between +50 mV and −125 mV with 25 mV intervals. Transient currents are
al currents by subtracting the capacitative and steady state currents. The transient
tted to the Boltzmann equation (materials and methods). Control oocytes did not
for DCT1, F227I, and I144F/F227I were: Qmax, 36, 32, and 33 nC; V0.5, 49, 46,
rent with the jump in potential to +50 mV was 64 ms (DCT1) and 22 ms (double
ff response.
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The uptake activity of Zn2+, Fe2+, Mn2+, and Co2+ in Xe-
nopus oocytes injected with cRNA of DCT1 or the I144F
mutant is shown in Fig. 2. The data are representative of at least
three experiments with oocytes from different frogs. The 1144F
mutation nearly abolished the transporter's uptake activity at pH
5.5 (Fig. 2) as well as pH 6.5 (data not shown).Fig. 4. The effect of Co2+ on the steady-state currents in the I144F mutant (A and
(A) 0.1 mM Co2+. The transient currents are plotted against time. Effect of imposed po
experiment was performed at pH 5.5 in the presence or absence of 0.1 mM ZnCl2 (t
Steady state substrate-induced currents (in the presence and absence of metal ion) we
the mean±SEM (n=4).3.2. Pre-steady state currents and metal ion-induced steady state
currents in oocytes expressing DCT1 and the I144F mutant
At pH 5.5 and a millisecond time scale, oocytes expressing
DCT1 exhibited pre-steady state currents, mainly at positively
imposed potentials [9,12] (Fig 3A). Pre-steady state currents are
an excellent indication of the level of transporter expression in
Xenopus oocytes [41]. With the addition of metal ion, pre-steadyB). The experiment was performed as described in Fig. 3, with (B) or without
tential on the steady-state currents induced by Zn2+, Mn2+, and Co2+ (C–F). The
riangles), MnCl2 (diamonds), or CoCl2 (squares—pH 5.5 and circles—pH 7.5).
re recorded at each voltage and plotted as a function of V. Each point represents
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peared, especially at negatively imposed potentials. In contrast,
pre-steady state currents were absent in oocytes injected with
cRNA of the mutant I144F (Figs. 3B and 4A, the absence of pre-
steady-state current in Fig. 3B can be seen from the current
records in Fig. 4A). Lack of transport and pre-steady state
activities indicates that the transporter was inactivated or failed to
assemble in the plasma membrane. Surprisingly, without ex-
ception (four independent mRNA injections), addition of metal
ion induced steady state currents that were up to 4.5-fold larger
then those of native DCT1 (Figs. 4A–D and 5D). Fig. 4C and D
shows the metal ion-induced currents generated in oocytes
expressing DCT1 and its I144F mutant at different imposed
potentials. At −125 mV, addition of 0.1 mM Co2+ or Mn2+
induced currents of 901±28 nA and 775±33 nA for the I144F
mutant and only 239±12 nA and 193±19 nA for DCT1. In
contrast, addition of Zn2+ induced similar currents of 168±30 nA
for the I144F mutant and 156±3 nA for DCT1. The same
phenomenon was also observed at induced potentials between
−25 mVand −125 mV.
The large positive metal ion-induced currents in DCT1-
expressing oocytes at a high proton concentration (pH 5.5) andFig. 5. Effect of Na+ on Co2+-induced currents at different imposed potentials. The ex
or choline-Cl. Steady state Co2+-induced currents (in the presence and absence of
(squares) of Na+ and plotted as a function of V. (A) DCT1. (B) I144F mutant. (C
concentration-dependence of the currents evoked by 0.1 mMCo2+ atVm=−125 mVand
Na+; n=3).negative membrane potentials are mainly due to proton
movement across the membrane [9,11]. Oocytes expressing
the I144F mutant were more sensitive to the presence of Na+ in
the solution than were oocytes expressing native DCT1 (Fig. 5A
and B). At −125 mV, exclusion of Na+ (replacing 100 mM
NaCl with choline-Cl) led to a 50% decrease in Co2+-induced
currents in oocytes expressing the I144F mutant (Fig. 5B) and a
20% decrease for oocytes expressing DCT1 (Fig. 5A). The
difference between mutant and native transporter was more
prominent at less negative potentials; at −50 mV, exclusion of
Na+ reduced the currents by 47% for the I144F mutant, without
affecting currents for DCT1 (Fig. 5A and B). In contrast to what
was found for oocytes expressing native DCT1, the magnitude
of Co2+-induced currents in oocytes expressing the I144F
mutant was dependent on the Na+ concentration (Fig. 5D). The
currents did not saturate at Na+ concentrations up to 100 mM at
any Vm tested (up to 125 mV) (Fig. 5D). A similar phenomenon
was observed for Mn2+-induced currents (data not shown). This
suggests that Na+ transport is part of the large positive inward
currents generated by the mutated transporter (sodium slip).
Similar properties of Na+-dependent unsaturated Na+ slip
were previously described for Smf1p, except that no proton slipperiment was performed as described for Fig. 3, in the presence of 100 mM NaCl
Co2+) were recorded for each voltage in the presence (diamonds) and absence
) I144F/F227I mutant. Each point represents the mean±SEM (n=4). (D) Na+
pHo 5.5 (squares, DCT1; diamonds, I144F mutant;R
2= 0.99, slope=5.35 nA/mM
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Also, in contrast to what was described for Smf1p, the slip
currents for the I144F mutant disappeared at pH 7.5 (Fig. 4D).
These results demonstrate the importance of position 144 in the
ion translocation pathway of DCT1 and in the mechanism
underlying slip.
Mutations F227I and I144F produced opposing effects. The
F227I mutation decreased the slip current without affecting the
uptake activity of the transporter ([10], Figs. 2 and 4E), while
the I144F mutation increased the slip currents and eliminated
uptake activity (Figs. 2 and 4D).
3.3. Metal ion uptake activity of the double mutant I144F/F227I
The logical next step was to generate and evaluate a F227I/
I144F double mutant. The uptake activity of Zn2+, Fe2+, Mn2+,
and Co2+ in Xenopus oocytes injected with cRNA of the I144F/
F227I mutant is shown in Fig. 2. As mentioned above, the
mutation I144F in TM2 (Fig. 1) abolished the uptake activity of
the transporter. However, elimination of an aromatic ring
(I144F/F227I) located two trans membrane domains after TM2
(TM4, Fig. 1) restored uptake of Fe2+, Mn2+, and Co2+ without
affecting the low level of Zn2+ uptake present with the I144F
mutant (Fig. 2). These results suggest proximity of these two
positions (144 and 227) in the folded structure of DCT1 and
support the importance of position 144 in metal ion transport.
3.4. Pre-steady state currents in the double mutant I144F/F227I
As mentioned above, unlike DCT1, the mutant I144F did not
exhibit pre-steady state currents (Fig. 3A and B). As we
previously reported [10], the F227I mutation did not signifi-
cantly affect the pre-steady state currents of DCT1. However,
the F227I mutation suppressed the effect of the I144F mutation,
restoring not only metal ion uptake activity (Fig. 2) but also the
pre-steady state currents (Fig. 3D). The magnitude of the pre-
steady state currents recorded in oocytes expressing native
DCT1, the F227I mutant, or the double mutant I144F/F227I
(Fig. 3A, B, and D) indicated similar levels of expression of the
three transporters. To characterize the features of the I144F/
F227I mutant, we subtracted the capacitative and steady state
currents to yield the transient current (Q) (Fig. 3D). At each
applied voltage, time integration of the off transients yielded the
charge moved. The charge–voltage (Q–V) relationship obtained
(data not shown) was fitted to a single Boltzmann function.
Similar Qmax of 36, 32, and 33 nC, similar V0.5 of 49, 46, and
51 mV, and similar z values of 2, 1.9 and 1.8 were extrapolated
from the fit for DCT1, F227I, and I144F/F227I, respectively.
The time constant ô for the pre-steady state current decay for
I144F/F227I, with a jump in potential from −25 mV to +50 mV,
was 22 ms for the on response and 13 ms for the off response,
whereas for DCT1, τ was 64 ms and 40 ms for the on and off
response, respectively. According to the Qmax, ∼2×1011
transporters were expressed on the plasma membrane of each
oocyte expressing DCT1, the F227I mutant, or the I144F/F227I
mutant. This calculation was made based on the mechanistic
concept of transient charge movements in ion-coupled trans-porters proposed by Wright and coworkers [30,42] for the Na+-
coupled glucose transporter SGLT1 and considering the
similarity between the pre-steady state properties of SGLT1
and DCT1. Essentially, the pre-steady state current results from
imposed potential induction of occlusion and release of protons
by DCT1 in the absence of substrate [1]. The decrease in ô for
the double mutant I144F/F227I might indicate increased
accessibility of protons to their binding sites on the mutated
transporter.
3.5. Metal Ion-Induced Steady State Currents in the Double
Mutant I144F/F227I
Addition of Mn2+ or Co2+ to oocytes expressing the I144F/
F227I mutant resulted in the disappearance of the pre-steady
state currents and appearance of steady state currents smaller
than those observed for native DCT1 (Fig. 4F). At −125 mV,
addition of Mn2+ or Co2+ induced inward positive currents of
193±19 nA or 239±12 nA for DCT1 (Fig. 4C) and 60±10 nA
or 46±14 nA for the I144F/F227I mutant (Fig. 4F). Addition of
Zn2+ abolished pre-steady state currents in oocytes expressing
the double mutant but induced similar currents of 156±3 nA
and 127±12 nA for DCT1 and the I144F/F227I mutant,
respectively. The double mutant partially retained the properties
of the F227I mutant (Fig 4E), exhibiting reduced slip currents
with Mn2+ and Co2+, and retained the response of I144F to Zn2+
(Fig 4F). Metal ion-induced currents of the double mutant were
not influenced by the presence or absence of Na+ in the solution
(Fig. 5C).
The functional properties of the two mutations encoded by
the mutated DCT1 gene in the most recently reported human
patient with congenital hypochromic microcytic anemia (in-
frame deletion of V145 and G243V) are unknown [28]. This
patient is a compound heterozygote for the two mutations in
DCT1. The prominent effects of the I144F mutation located
immediately before V145 demonstrate the transporter's sensi-
tivity to alterations in this region. It is probable that deletion of
V145 severely impairs transporter activity.
4. Discussion
The advantage of precision in biological processes is
obvious. However, in many cases, deviations from faithful
mechanisms occur. The terms “slips” and “leaks” have been
used to describe deviation from the expected stoichiometry of
an operating system [43–46]. We use the term slip to describe a
built-in feature of a specific protein or complex and the term
leak to describe a general property of the membrane, that is,
summation of the membrane's permeability.
DCT1 and Smf1p are quintessential examples of transporters
that generate a built-in slip current as part of their mechanism of
action. In both DCT1 and Smf1p transporters, protons are the
driving force for metal ion uptake [9,12–14]. Under conditions
of neutral pH and/or neutral membrane potential, DCT1 is in the
coupled state; the stoichiometry of proton: metal ion transport is
close to 1:1. Increasing the driving force by reducing the pH or
increasing the negative potential generates a proton slip, which
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the normal rates for the coupled state. However, slip significantly
increases the rate of proton movement through the transporter. A
similar mechanism applies to Smf1p-mediated slip, except that
Na+ slips rather than H+. Na+ inhibits the metal ion uptake by
Smf1P [11,14]. The physiological significance of this phenome-
nonmay be that it protects cells against excessive transport of these
elements. Such a mechanism is necessary when cells are exposed
to conditions of abundant metals and an acidic environment. We
propose that slips are fundamental to life processes, enabling cells
to cope with stressful situations created by transitory extreme
conditions, which might otherwise impair cell functioning and
jeopardize its health. However, the mechanism underlying H+ and
Na+ slip in metal ion transporters is unclear.
To locate the transporter sites that generate slip, we used
reciprocal amino acid substitution between DCT1 and Smf1p to
manipulate slip magnitude and ion composition. Substitution of
a single amino acid in F227I in TM4 reduced proton slip through
DCT1 without significantly affecting metal ion transport [10].
This mutation did not generate Na+ slip, and the transporter
properties were unaffected by removal of Na+ from the bathing
medium [10]. However, mutation I144F in TM2 increased slip
currents induced by Co2+ and Mn2+ (but not Zn2+) and
eliminated the transporter's metal ion transport activity (Fig. 2
and 4D). In the presence of metal ions, there was charge slip, but
the metal ion was not transported across the membrane. In
addition to the proton slip mutation I144F of DCT1 also
produced Na+ slip (Fig. 5). The loss of metal ion transport ability
with this mutation could be explained by the increase in slip
currents. However, reduction of proton concentration or
omission of Na+ did not increase uptake activity (data not
shown). These results demonstrate the importance of position
144 to metal ion transport, ion permeability, and ion selectivity.
It appears that this position participates in formation of the
translocation pathway in DCT1 and Smf1p, and it is probably
one of the sites responsible for generating sodium slip in Smf1p.
The mutation I144F did not generate any pre-steady state
currents. This could be due to changes in the proton-binding site
of the transporter; according to the mechanistic concept of tran-
sient charge movements [30,42], the pre-steady state current
results from occlusion and release of protons by DCT1 in re-
sponse to imposed membrane potential in the absence of sub-
strate. We propose that this position also participates in the
formation of the proton-binding site of DCT1. The F227I sub-
stitution in the I144F mutant (I144F/F227I) suppressed the effect
of the I144F mutation, restored its metal ion uptake (Fe2+, Co2+,
andMn2+ but not Zn2+) and pre-steady state currents, and reduced
metal ion-induced (Co2+ andMn2+ but not Zn2+) slip currents to a
level below that for native DCT1 (Figs. 2, 3D and 4D). This
substitution might restore the environment of the proton-binding
site and the metal ion translocation pathway to their state in native
DCT1, thus enabling pre-steady state currents and metal ion
uptake. These findings suggest that position 144 in TM2 and
position 227 in TM4 are located in close proximity within the
folded structure of DCT1.
Differences in Zn2+ transport and Zn2+-induced steady state
currents for the various mutations are noteworthy. The F227Imutant transported Zn2+ and produced smaller steady state
currents than those observed for native DCT1, thus increasing the
coupling between Zn2+ and protons ([10], Figs. 2 and 4E). The
I144F mutant did not transport Zn2+ or any other metal ion tested;
also, it increased the steady state currents induced by Mn2+ and
Co2+ but not Zn2+ (Figs. 2 and 4D). The double mutant I144F/
F227I transported Mn2+ and Co2+, but not Zn2+, and did not
reduce Zn2+-induced steady state currents, an indication that the
double mutation does not increase coupling between Zn2+ and
protons (Figs. 2 and 4D). Therefore, this region of DCT1 is likely
involved in the transporter's metal ion and proton coupling, and
metal ion specificity. Further studies will be required to identify
the binding sites and the translocation pathway that was
influenced by the I144F and F227I mutations in DCT1.
Our findings suggest that aromatic residues in DCT1, and
probably in other family members, play an important mecha-
nistic role. Previous studies have established the importance of
aromatic residues to protein–ligand recognition (including tran-
sitional metal ions and protons) and the establishment of protein
structure [33–40]. Cation–pi interactions are common among
structures in the Protein Data Bank, and it is clear that the
presence of a cationic residue (Lys or Arg) near an aromatic
residue (Phe, Tyr, or Trp) biases the geometry so as to promote a
favorable cation–pi interaction [34]. The Arg residue is more
likely than Lys to participate in a cation–pi interaction [34]. The
highly conserved arginine reside in position 151 (Fig. 1), seven
amino acids after I144, could be located in the same region as
I144 and F227, two turns further in an α-helix structure.
Substitution of R151 to Y decreased metal ion transport by up to
90% (Sacher, A., unpublished results). Lam-Yuk-Tseung et al.
showed that the mutation R151A fully complemented the
susceptibility of the yeast smf1/smf2 mutant (where SMF1 and
SMF2 genes are insertionally inactivated) to the metal chelator
EGTA [22]. However, as we observed from our previous studies,
manganese uptake activity of approximately 10% was sufficient
to complement the yeast null SMF1 mutant [12]. The R151
residue may participate in a cation–pi interaction with F227 in
this region of DCT1. There has been great progress in structure–
function analyses of the Nramp family [10,12,15,22,47,48].
However, only a high-resolution structure of one or more family
members can confirm these predictions and provide a detailed
description of the unusual operating mechanism for this
important family of metal ion transporters.
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